Tibia bone shaft fracture. Fracture of shaft of tibia
Conditions
Interventions
Intervention 1: Administration of oral mummy drug, daily total of four capsules, for 4 weeks, each capsule contains 250 mg of oral mummy drug. It should be taken with water one hour before or three ho
Treatment - Drugs
Placebo
Administration of oral mummy drug, daily total of four capsules, for 4 weeks, each capsule contains 250 mg of oral mummy drug. It should be taken with water one hour before or three hours after meals.
Administration of Golha wheat flour (0000) in form of edible capsules similar to the packaging of oral mummy drug, a total of four capsules daily for 4 weeks
Sponsors
Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. The male gender 2. Fracture of tibia bone shaft 3. Initiation of intervention in less than 10 days from the time of fracture 4. Age between 18 and 50 5. Completing the consent form Exclusion criteria: 1. Orthopedic complication that prevents the continuation of the research process (in consultation with orthopedic surgeon and researcher) 2. The unpredictable complications leading to intolerance of medication or placebo such as idiosyncratic complications (in consultation with orthopedic surgeon and researcher) 3. Taking medications that affecting the bone repair 4. Surgery again 5. Pathological fracture 6. Underlying disease affecting the recovery process of fractures of the bone (immunodeficiency, tumor, osteoporosis, liver or renal failure) 7. Addiction 8. Severe infection of the bone or tissue around the location of the fracture or damage of the artery (according to the criteria of the Gustillo-Anderson 3C or 3B)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Union time of tibia bone shaft fracture. Timepoint: Two, four, six, eight, ten and twelve weeks after the start of the intervention. Method of measurement: Swiss-ray digital radiology device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Two, four, six, eight, ten and twelve weeks after the start of the intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSayed Mohammad Hassan Sadeghi
School of Traditional Medicine, Shahid Beheshti University of Medical Sciences
Outcome results
None listed